PMS2 and mismatch repair cancer syndrome 1: Mismatch repair deficiency (MMRd) correlated with higher engraftment rates: mismatch repair deficiency, measured by immunohistochemistry in tumor tissue, describes cells that have mutations in certain genes that are involved in DNA repair (mismatch repair genes: MLH1, MSH2, MSH6 and PMS2).